-
Je něco špatně v tomto záznamu ?
Hydnocarpin-Type Flavonolignans: Semisynthesis and Inhibitory Effects on Staphylococcus aureus Biofilm Formation
V. Vimberg, M. Kuzma, E. Stodůlková, P. Novák, L. Bednárová, M. Šulc, R. Gažák,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- antioxidancia MeSH
- biofilmy účinky léků MeSH
- flavonolignany chemie izolace a purifikace farmakologie MeSH
- molekulární struktura MeSH
- nukleární magnetická rezonance biomolekulární MeSH
- ostropestřec mariánský chemie MeSH
- silymarin chemie MeSH
- Staphylococcus aureus účinky léků MeSH
- vysokoúčinná kapalinová chromatografie MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A new, efficient, and general semisynthesis of hydnocarpin-type flavonolignans was developed and optimized, enabling gram-scale production of hydnocarpin D (2). Moreover, the syntheses of optically pure hydnocarpin isomers [(10R,11R)-hydnocarpin (1a), (10R,11R)-hydnocarpin D (2a), and (10S,11S)-hydnocarpin D (2b)], as well as the synthesis of isohydnocarpin (8), were achieved for the first time utilizing this new method. The synthesis is based on the two-step transformation of the readily available flavonolignans from milk thistle (Silybum marianum), accessible by isolation from the commercial extract silymarin. The first step relies on the regioselective formylation of the C-3 hydroxy group of the dihydroflavonol-type precursor using the Vilsmeier-Haack reagent, followed by formic acid elimination by triethylamine in the second step. The synthesized compounds were effective inhibitors of Staphylococcus aureus biofilm formation, with (10S,11S)-hydnocarpin D (2b) being the most potent inhibitor. Furthermore, the effect of glucose on biofilm formation was tested, and glucose decreased the biofilm inhibitory activity of 2b. Moreover, 2b increased the susceptibility of Staph. aureus to enrofloxacin.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000060
- 003
- CZ-PrNML
- 005
- 20160126102513.0
- 007
- ta
- 008
- 160108s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jnatprod.5b00430 $2 doi
- 035 __
- $a (PubMed)26273725
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vimberg, Vladimir $u Institute of Microbiology of the Academy of Sciences of the Czech Republic , v.v.i., Vídeňská 1083, Prague 4, CZ 142 20, Czech Republic.
- 245 10
- $a Hydnocarpin-Type Flavonolignans: Semisynthesis and Inhibitory Effects on Staphylococcus aureus Biofilm Formation / $c V. Vimberg, M. Kuzma, E. Stodůlková, P. Novák, L. Bednárová, M. Šulc, R. Gažák,
- 520 9_
- $a A new, efficient, and general semisynthesis of hydnocarpin-type flavonolignans was developed and optimized, enabling gram-scale production of hydnocarpin D (2). Moreover, the syntheses of optically pure hydnocarpin isomers [(10R,11R)-hydnocarpin (1a), (10R,11R)-hydnocarpin D (2a), and (10S,11S)-hydnocarpin D (2b)], as well as the synthesis of isohydnocarpin (8), were achieved for the first time utilizing this new method. The synthesis is based on the two-step transformation of the readily available flavonolignans from milk thistle (Silybum marianum), accessible by isolation from the commercial extract silymarin. The first step relies on the regioselective formylation of the C-3 hydroxy group of the dihydroflavonol-type precursor using the Vilsmeier-Haack reagent, followed by formic acid elimination by triethylamine in the second step. The synthesized compounds were effective inhibitors of Staphylococcus aureus biofilm formation, with (10S,11S)-hydnocarpin D (2b) being the most potent inhibitor. Furthermore, the effect of glucose on biofilm formation was tested, and glucose decreased the biofilm inhibitory activity of 2b. Moreover, 2b increased the susceptibility of Staph. aureus to enrofloxacin.
- 650 _2
- $a antioxidancia $7 D000975
- 650 _2
- $a biofilmy $x účinky léků $7 D018441
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $7 D002851
- 650 _2
- $a flavonolignany $x chemie $x izolace a purifikace $x farmakologie $7 D044947
- 650 _2
- $a ostropestřec mariánský $x chemie $7 D020944
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a nukleární magnetická rezonance biomolekulární $7 D019906
- 650 _2
- $a silymarin $x chemie $7 D012838
- 650 _2
- $a Staphylococcus aureus $x účinky léků $7 D013211
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kuzma, Marek $u Institute of Microbiology of the Academy of Sciences of the Czech Republic , v.v.i., Vídeňská 1083, Prague 4, CZ 142 20, Czech Republic.
- 700 1_
- $a Stodůlková, Eva $u Institute of Microbiology of the Academy of Sciences of the Czech Republic , v.v.i., Vídeňská 1083, Prague 4, CZ 142 20, Czech Republic.
- 700 1_
- $a Novák, Petr $u Institute of Microbiology of the Academy of Sciences of the Czech Republic , v.v.i., Vídeňská 1083, Prague 4, CZ 142 20, Czech Republic. Department of Biochemistry, Faculty of Science, Charles University in Prague , Hlavova 8, Prague 2, CZ 128 40, Czech Republic.
- 700 1_
- $a Bednárová, Lucie $u Institute of Organic Chemistry and Biochemistry of the AS CR , v.v.i., Flemingovo náměstí 2, Prague 6, CZ 166 10, Czech Republic.
- 700 1_
- $a Šulc, Miroslav $u Institute of Microbiology of the Academy of Sciences of the Czech Republic , v.v.i., Vídeňská 1083, Prague 4, CZ 142 20, Czech Republic. Department of Biochemistry, Faculty of Science, Charles University in Prague , Hlavova 8, Prague 2, CZ 128 40, Czech Republic.
- 700 1_
- $a Gažák, Radek $u Institute of Microbiology of the Academy of Sciences of the Czech Republic , v.v.i., Vídeňská 1083, Prague 4, CZ 142 20, Czech Republic.
- 773 0_
- $w MED00010055 $t Journal of natural products $x 1520-6025 $g Roč. 78, č. 8 (2015), s. 2095-103
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26273725 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20160126102636 $b ABA008
- 999 __
- $a ok $b bmc $g 1102341 $s 924266
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 78 $c 8 $d 2095-103 $e 20150814 $i 1520-6025 $m Journal of natural products $n J Nat Prod $x MED00010055
- LZP __
- $a Pubmed-20160108